QI
NKTR icon

QS Investors’s Nektar Therapeutics NKTR Stock Holding History

QS Investors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-307
Closed -$107K – 1414
2020
Q2 		$107K Hold
307
– – ﹤0.01% 1300
2020
Q1 		$83K Hold
307
– – ﹤0.01% 1309
2019
Q4 		$97K Sell
307
-123
-29% -$35.7K ﹤0.01% 1396
2019
Q3 		$118K Hold
430
– – ﹤0.01% 1342
2019
Q2 		$230K Hold
430
– – ﹤0.01% 1185
2019
Q1 		$217K Sell
430
-1
-0.2% -$593 ﹤0.01% 1196
2018
Q4 		$213K Sell
431
-1,767
-80% -$1.07M ﹤0.01% 1106
2018
Q3 		$2.01M Hold
2,198
– – 0.02% 624
2018
Q2 		$1.61M Buy
2,198
+1,834
+504% +$2.11M 0.02% 657
2018
Q1 		$580K Buy
364
+123
+51% +$158K 0.01% 904
2017
Q4 		$216K Buy
241
+1
+0.4% +$591 ﹤0.01% 1176
2017
Q3 		$86K Hold
240
– – ﹤0.01% 1428
2017
Q2 		$70K Sell
240
-2
-0.8% -$578 ﹤0.01% 1450
2017
Q1 		$85K Buy
242
+240
+12,000% +$53.9K ﹤0.01% 1419
2016
Q4 		$1K Hold
2
– – ﹤0.01% 1682
2016
Q3 		$1K Buy
2
+1
+100% +$257 ﹤0.01% 1671
2016
Q2 		$1K Buy
+1
New +$224 ﹤0.01% 1714
2016
Q1 		– Sell
-2,219
Closed -$561K – 2029
2015
Q4 		$561K Buy
2,219
+1
+0% +$206 0.01% 884
2015
Q3 		$365K Sell
2,218
-19
-0.8% -$3.36K ﹤0.01% 948
2015
Q2 		$420K Hold
2,237
– – 0.01% 909
2015
Q1 		$370K Buy
2,237
+19
+0.9% +$3.9K ﹤0.01% 936
2014
Q4 		$516K Buy
+2,218
New +$474K 0.01% 850

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

QS Investors's NKTR Position: Q3 2020 in Review

QS Investors sold out of Nektar Therapeutics (NKTR) in Q3 2020, closing a stake of 307 shares — an estimated $107K sold.

QS Investors first reported a position in NKTR in Q4 2014 and held it in 22 quarters. The position peaked at $2.01M in Q3 2018. 248 funds tracked by Wall St. Rank hold NKTR as of Q3 2020.

  • QS Investors reported no remaining Nektar Therapeutics position as of Q3 2020 after selling out during the quarter.
  • QS Investors sold 307 Nektar Therapeutics shares in Q3 2020, an estimated $107K.
  • QS Investors first reported a position in Nektar Therapeutics in Q4 2014 and held it in 22 quarters.
  • QS Investors's Nektar Therapeutics position peaked at $2.01M in Q3 2018.
  • 248 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.